In pathology, Immunohistochemical staining (IHC) of tissue sections is regularly used to diagnose and grade malignant tumors. Typically, IHC stain interpretation is rendered by a trained pathologist using a manual method, which consists of counting e...
The World Health Organization (WHO) has clear guidelines regarding the use of Ki67 index in defining the proliferative rate and assigning grade for pancreatic neuroendocrine tumor (NET). WHO mandates the quantification of Ki67 index by counting at le...
Being a non-histone protein, Ki-67 is one of the essential biomarkers for the immunohistochemical assessment of proliferation rate in breast cancer screening and grading. The Ki-67 signature is always sensitive to radiotherapy and chemotherapy. Due t...
Because of the limited number of tumor markers in veterinary medicine, there is need for identifying new markers. Ki-67 has been investigated as a tissue marker of malignant alterations. We hypothesized that Ki-67 would also be measurable in serum an...
PURPOSE: To develop a multiparametric breast MRI radiomics and deep learning-based multimodal model for predicting preoperative Ki-67 expression status in breast cancer, with the potential to advance individualized treatment and precision medicine fo...
Computer methods and programs in biomedicine
Jul 1, 2025
OBJECTIVES: Achieving efficient analysis of multiple pathological indicators has great significance for breast cancer prognosis and therapeutic decision-making. In this study, we aim to explore a deep multi-task learning (MTL) framework for collabora...
JPMA. The Journal of the Pakistan Medical Association
Apr 1, 2024
Breast Cancer (BC) has evolved from traditional morphological analysis to molecular profiling, identifying new subtypes. Ki-67, a prognostic biomarker, helps classify subtypes and guide chemotherapy decisions. This review explores how artificial inte...
OBJECTIVE: This retrospective observational study aims to develop and validate artificial intelligence (AI) pathomics models based on pathological Hematoxylin-Eosin (HE) slides and pathological immunohistochemistry (Ki67) slides for predicting the pa...
Technology in cancer research & treatment
Jan 1, 2024
To establish a model based on clinical and delta-radiomic features within ultrasound images using XGBoost machine learning to predict proliferation-associated nuclear antigen Ki-67 value ≥ 15% in TNM stage primary breast cancer (BC). Data were coll...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.